Abstract
ATAGI has issued clinical guidance for COVID-19 immunisation providers and program staff based on currently available data.
It provides recommendations on the use of the Pfizer COVID-19 vaccine Comirnaty and the AstraZeneca COVID-19 Vaccine. It will be updated as new information and vaccines become available.
Changes from the previously available ATAGI Clinical guidance on COVID-19 vaccines in Australia (v1.0) include:
- Inclusion of data on the AstraZeneca COVID-19 Vaccine
- Changes in COVID-19 vaccine precautions for people with a history of allergy
- Recommendation
- Western Pacific
- Australia
- clinical guidance
- COVID-19